Company: BSX
Filing Date: 2025-08-01
Form Type: 10-Q
Source: 0000885725-25-000041
Chunk: 147

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-08-01
Form: 10-Q
Item: Part I, Item 8
Chunk 147
---
1,163 2,637 Total Net Sales$3,224 $1,837 $5,061 $2,466 $1,654 $4,120 Six Months Ended June 30,20252024BusinessesU.S.Int'lTotalU.S.Int'lTotalEndoscopy$876 $534 $1,410 $810 $508 $1,318 Urology967 342 1,310 719 319 1,038 Neuromodulation432 142 574 405 134 539 MedSurg2,275 1,018 3,293 1,933 961 2,895 Interventional Cardiology Therapies484 944 1,428 396 921 1,316 Watchman836 75 911 653 70 723 Cardiac Rhythm Management713 455 1,168 706 446 1,151 Electrophysiology1,099 472 1,570 429 300 729 Cardiology3,131 1,945 5,077 2,183 1,736 3,919 Peripheral Interventions778 576 1,354 608 555 1,163 Cardiovascular3,909 2,521 6,430 2,791 2,291 5,082 Total Net Sales$6,185 $3,539 $9,724 $4,724 $3,252 $7,977 Refer to Note J – Segment Reporting for information on our reportable segments.

35

Three Months Ended June 30,Six Months Ended June 30,Geographic Regions2025202420252024U.S.$3,224 $2,466 $6,185 $4,724 Europe, Middle East and Africa878 822 1,725 1,625 Asia-Pacific790 670 1,491 1,317 Latin America and Canada169 162 324 311 Total Net Sales$5,061 $4,120 $9,724 $7,977 Emerging Markets(1)$758 $680 $1,449 $1,328 (1) Our Emerging Markets countries include all countries except the United States, Western and Central Europe, Japan, Australia, New Zealand and Canada